Frank Karbe's Net Worth
Frank Karbe's net worth is estimated to be at least $2,005,818.28 as of 12/23/2024. CoreStreet's estimation of Frank Karbe's net worth is based on their sale of stock and current holding of stock.
Frank Karbe is Director at Phathom Pharmaceuticals Inc. They have executed at least 14 trades of stock as per SEC Form 4 filings. Their most recent trade was for 12,500 units of PHAT stock on 12/13/2024. Their biggest sale was on 08/31/2020 when they sold 24,800 units of Myovant Sciences Ltd stock for $496,496.00. They typically trade 2 times per year.
Total value of insider buys:
- $575,226.33
Total value of insider sells:
- $1,430,591.95
Most recent insider trade:
- Dec. 13, 2024
Frank Karbe's Insider Trading History
| Phathom Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 13, 2024 | Director | 12,500 | $7.93 | Buy | $99,125.00 |
| Better Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 27, 2023 | CEO | 137,005 | $0.73 | Buy | $100,013.65 |
April 10, 2023 | Insider | 242,424 | $0.82 | Buy | $198,787.68 |
Sept. 15, 2022 | Insider | 50,000 | $2.09 | Buy | $104,500.00 |
| Myovant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 6, 2021 | Insider | 11,080 | $18.63 | Sell | $206,420.40 |
Jan. 28, 2021 | Insider | 300 | $24.00 | Sell | $7,200.00 |
Jan. 15, 2021 | Insider | 750 | $21.50 | Sell | $16,125.00 |
Dec. 28, 2020 | Insider | 11,800 | $30.00 | Sell | $354,000.00 |
Nov. 17, 2020 | Insider | 750 | $20.00 | Sell | $15,000.00 |
Nov. 13, 2020 | Insider | 750 | $20.00 | Sell | $15,000.00 |
Aug. 31, 2020 | Insider | 24,800 | $20.02 | Sell | $496,496.00 |
Aug. 19, 2020 | Insider | 700 | $20.00 | Sell | $14,000.00 |
Dec. 30, 2019 | Insider | 19,701 | $15.55 | Sell | $306,350.55 |
June 11, 2019 | Insider | 8,000 | $9.10 | Buy | $72,800.00 |